The Mini-Mental State Examination (MMSE) can flag possible dementia, but it cannot diagnose dementia by itself. At common cutoffs, it detects about 85% to 89% of dementia cases and correctly clears about 90% of people without dementia. The MMSE is an 11-item, 30-point cognitive screening test. Its value lies in identifying who may need a fuller assessment—not in naming the cause of cognitive changes.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What does the MMSE result mean?
- How accurate is the MMSE for dementia?
- Why can accuracy change?
- How much does the MMSE cost?
- What should happen after the test?
What does the MMSE result mean?
A clinician uses the mmse to obtain a brief measure of cognitive performance. The test itself generally takes 7 to 10 minutes, although administration time varies by version. A low score indicates possible cognitive impairment.
It does not establish that someone has dementia, determine the type of dementia, or rule out another explanation. The USPSTF describes the MMSE as a screening instrument, meaning its result must be interpreted alongside other evidence. The score matters most when compared with the person's history and ability to manage daily activities. symptoms can still deserve evaluation even when the score does not cross the chosen cutoff.
How accurate is the MMSE for dementia?
In 14 studies involving 11,972 people, MMSE cutoffs of 23 or 24 or lower produced pooled sensitivity of 89% and specificity of 90%. Sensitivity describes how often the test identifies people who have dementia. Specificity describes how often it correctly classifies people who do not. In practical terms, 89% sensitivity means about 11 of every 100 people who truly have dementia could screen negative.
A specificity of 90% means about 10 of every 100 people without dementia could screen positive. A Cochrane review of community samples aged 65 and older found similar limitations. At a cutoff of 24, the test detected 85% of dementia cases and correctly classified 90% of people without dementia. These figures show why both false reassurance and unnecessary alarm are possible.
Why can accuracy change?
Accuracy depends partly on where the cutoff is placed. Raising the cutoff may identify more people with impairment, but it can also classify more unaffected people as positive. The Cochrane review reported 87% sensitivity and 82% specificity at a cutoff of 25. Education-adjusted estimates increased sensitivity to 97% but reduced specificity to 70%.
That tradeoff matters for individual decisions. A more sensitive approach misses fewer cases, while lower specificity produces more false positives. It also helps explain why a score should not be interpreted without personal and clinical context. The USPSTF found insufficient evidence to determine whether routine cognitive screening of all older adults produces more overall benefit than harm. That finding concerns population-wide screening; it does not make reported symptoms or an abnormal result irrelevant.
How much does the MMSE cost?
The cost of MMSE materials is not the same as the amount a patient pays. A January 2020 USPSTF evidence summary reported materials costing about $1.86 per form plus an $88 manual at that time. Current MMSE-2 materials are commercially sold.
PAR lists a Standard Version kit at $268 and gives estimated administration times of 5 minutes for the Brief version, 10 to 15 minutes for the Standard version, and 20 minutes for the Expanded version. Those are product prices and testing times, not a complete clinical bill. Medicare says a fuller cognitive-assessment visit is separately covered under Part B. After the deductible, beneficiaries generally pay 20% of the Medicare-approved amount, although the actual out-of-pocket cost depends on coverage and the care setting.
What should happen after the test?
An abnormal MMSE result should lead to evaluation rather than an immediate dementia label. A normal score also should not end the inquiry when cognitive or functional changes remain concerning, because the test can miss dementia cases.
Useful preparation for the next appointment includes: According to the National Institute on Aging's diagnostic guidance, clinicians may combine medical history, functional and cognitive testing, medication review, laboratory tests, and psychiatric evaluation. Depending on the findings, they may also use CT, MRI, or PET imaging or refer the person to a specialist.
- Record when the changes began and how they affect daily activities.
- Bring a complete medication list.
- Ask how the score was interpreted and whether the cutoff was adjusted.
- Request information about further testing or specialist referral.
